Clinical Trials
The OSPREY Study
Did you know that OSA is the most common type of sleep apnea? The OSPREY study researches the effectiveness of a new, innovative medical device called the aura6000 for moderate to severe OSA. The device treats obstructive sleep apnea using targeted hypoglossal neurostimulation, and is an alternative to the CPAP machine for treating sleep apnea. It has been approved by the FDA to commence an investigational device exemption (IDE) clinical study with Dr. Schalch Lepe as the principal investigator. Find out if you qualify to participate in this study by clicking on the button below:
Watch Video to Learn More
Featured Publications
Functional endoscopic dilatation of the sinuses (FEDS): Patient selection and surgical technique
Surgery of the palate and oropharynx.
Palatal stiffening after failed uvulopalatopharyngoplasty with the Pillar Implant System.
Middle turbinate medialization with bovine serum albumin tissue adhesive (BioGlue).
Upper esophageal pH monitoring: Transnasal placement of the Bravo wireless capsule system
Middle turbinate medialization with bovine serum albumin tissue adhesive (BioGlue).
Functional endoscopic dilatation of the sinuses: patient satisfaction, postoperative pain, and cost.
Specializing in the treatment of a variety of conditions (deviated septum, nasal obstruction, snoring, obstructive sleep apnea, etc.), Dr. Schalch Lepe is highly qualified and motivated to provide his patients with the best possible treatment results. Dr. Schalch Lepe takes an in-depth, personalized approach with each patient to ensure they receive the best possible treatment for their situation.
Originally from Mexico City, Mexico, Dr. Schalch Lepe has the unique perspective of having trained in multiple countries. This experience has led him to be sought out by domestic and international patients, many of whom are Mexican ex-pats living throughout San Diego County and Southern California.